COVID‐19 “second wave” and vaccines: the dermatologists’ perspective

Burlando, Martina; Russo, Roberto; Cozzani, Emanuele; Parodi, Aurora

doi:10.1111/ijd.15547

Cited by 20 publications

(34 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Perhaps, the acquired knowledge of the cutaneous manifestations associated with COVID-19 has resulted in a reduction in the number of case reports. In fact, manuscripts that are accepted in journals are larger cohort studies and/or based on clinical registries of COVID-19 [57]. On the other hand, new SARS-CoV-2 mutations and variants may have resulted in fewer cutaneous manifestations, possibly due to reduced viral cutaneous tropism or by inducing different immune responses [57].…”

Section: New Sars-cov-2 Variants and Skin Manifestationsmentioning

confidence: 99%

“…In fact, manuscripts that are accepted in journals are larger cohort studies and/or based on clinical registries of COVID-19 [57]. On the other hand, new SARS-CoV-2 mutations and variants may have resulted in fewer cutaneous manifestations, possibly due to reduced viral cutaneous tropism or by inducing different immune responses [57]. Nonetheless, further studies are needed to confirm this as well as the influence of vaccination.…”

Section: New Sars-cov-2 Variants and Skin Manifestationsmentioning

confidence: 99%

See 1 more Smart Citation

Identification, Mechanism, and Treatment of Skin Lesions in COVID-19: A Review

Fernández-Lázaro

Garrosa

2021

Viruses

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID-19) is a multisystem disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), that primarily causes respiratory symptoms. However, an increasing number of cutaneous manifestations associated with this disease have been reported. The aim of this study is to analyze the scientific literature on cutaneous manifestations associated with SARS-CoV-2 by means of a narrative literature review until June 2021. The search was conducted in the following electronic databases: Medline (PubMed), SciELO, and Cochrane Library Plus. The most common cutaneous manifestations in patients with COVID-19 are vesicular eruptions, petechial/purpuric rashes, acral lesions, liveoid lesions, urticarial rash, and maculopapular-erythematous rash. These manifestations may be the first presenting symptoms of SARS-CoV-2 infection, as is the case with acral lesions, vesicular eruptions, and urticaria. In relation to severity, the presence of liveoid lesions may be associated with a more severe course of the disease. Treatment used for dermatological lesions includes therapy with anticoagulants, corticosteroids, and antihistamines. Knowledge of the dermatologic manifestations associated with SARS-CoV-2 contributes to the diagnosis of COVID-19 in patients with skin lesions associated with respiratory symptoms or in asymptomatic patients. In addition, understanding the dermatologic lesions associated with COVID-19 could be useful to establish a personalized care plan.

show abstract

Section: New Sars-cov-2 Variants and Skin Manifestationsmentioning

confidence: 99%

Section: New Sars-cov-2 Variants and Skin Manifestationsmentioning

confidence: 99%

Identification, Mechanism, and Treatment of Skin Lesions in COVID-19: A Review

Fernández-Lázaro

Garrosa

2021

Viruses

View full text Add to dashboard Cite

show abstract

“…Cutaneous lesions related to COVID‐19 may be attributed to a collateral effect of the activation of the immune system rather than being a direct effect of the virus, despite relatively common 2 . Cutaneous reactions following COVID‐19 vaccination, such as herpes zoster and lichen planus, have been reported 3 . Herein, we present two cases who developed acral chilblain‐like lesions (CLL) after the inactivated SARS‐CoV‐2 vaccine ( CoronaVac, by Sinovac Life Sciences, Beijing, China ) to draw attention to the possible cutaneous side effects of the vaccine.…”

Section: Figurementioning

confidence: 99%